Riskpilot← Back to searchSign inGet full accessMEDICOLINE ApS
APSActiveCVR 33046960Søndre Viaduktvej 11Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20101 employees
Revenue 2024
DKK 853K
+23% vs 2023
EBITDA margin
36.6%
+78% vs 2023
Equity ratio
68.5%
Financial strength
Net profit 2024
DKK 204K
+94% vs 2023
| Revenue | DKK 853K | +23% |
| EBITDA | DKK 312K | +78% |
| Net profit | DKK 204K | +94% |
| Total assets | DKK 1,1M | +20% |
| Equity | DKK 767K | +36% |
| Employees | 1 | — |
Legal name
MEDICOLINE ApS
CVR number
33046960
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. juni 2010
Share capital
DKK 80.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at sælge medicinalprodukter til sundhedssektoren, medicinske skønheds produkter / skønhedsrelaterede produkter og anden efter direktionens skøn beslægtet virksomhed
Address
Søndre Viaduktvej 11
Phone
+4536166488
Email
info@medicoline.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 469 | 1.156 | 809 | 820 | 566 | 482 | 517 | 809 | 752 | 808 | 667 | 696 | 853 |
| Staff expenses | -840 | -618 | -606 | -600 | -498 | -569 | -488 | -602 | -562 | -623 | -531 | -520 | -540 |
| EBITDA | -404 | 538 | 195 | 201 | 68 | -87 | 29 | 207 | 190 | 185 | 136 | 176 | 312 |
| Depreciation & amort. | 69 | -69 | -72 | -17 | -12 | -10 | -10 | -9 | -3 | -0 | -0 | -8 | -15 |
| EBIT | -473 | 469 | 123 | 184 | 55 | -97 | 18 | 198 | 187 | 185 | 136 | 168 | 298 |
| Net financials | -24 | -17 | -13 | -24 | -5 | 8 | -1 | -27 | -42 | -63 | -25 | -29 | -35 |
| Profit before tax | -252 | 452 | 109 | 160 | 51 | -51 | 18 | 171 | 145 | 122 | 110 | 140 | 263 |
| Tax | 122 | 113 | 30 | 39 | 13 | 19 | 5 | 40 | 36 | 29 | 26 | 34 | 59 |
| Net profit | -375 | 338 | 79 | 121 | 37 | -70 | 13 | 131 | 109 | 93 | 85 | 105 | 204 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 970 | 824 | 750 | 687 | 745 | 693 | 717 | 922 | 1.020 | 750 | 703 | 932 | 1.120 |
| Equity | -78 | 261 | 340 | 461 | 498 | 428 | 441 | 471 | 381 | 373 | 458 | 563 | 767 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.047 | 563 | 410 | 226 | 247 | 265 | 277 | 450 | 639 | 377 | 245 | 369 | 353 |
| Total debt | 1.047 | 563 | 410 | 226 | 247 | 265 | 277 | 450 | 639 | 377 | 245 | 369 | 353 |
EBITDA margin
36.6%
This company
15.8%
Market median
+132% vs market
20122024
Equity ratio
68.5%
This company
38.2%
Market median
+79% vs market
20122024
Return on equity
26.6%
This company
18.4%
Market median
+45% vs market
20122024
Net profit margin
24.0%
This company
8.1%
Market median
+196% vs market
20122024
Asset turnover
0.76×
This company
1.12×
Market median
-32% vs market
20122024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LP Management | Management | 2010 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MEDICOLINE HOLDING ApS | Company | 100.0% | 100.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDICOLINE HOLDING ApS
MEDICOLINE ApS Board members of MEDICOLINE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lotte Persson | Management | 0 companies |